In a moment that felt like a new chapter cracking open for Nigeria’s healthcare and pharmaceutical landscape, AMA Medical Manufacturing Ltd (AMA-MED) held the groundbreaking ceremony for its Central Commodity & Logistics Management Centre on Wednesday, November 26, 2025.

The foundation-laying was performed by Senator (Dr.) Jerome Walcott, Minister of Health and Wellness, Republic of Barbados, whose presence signalled strong international confidence in Nigeria’s expanding pharmaceutical potential.

Addressing invited guests before turning the earth, Dr. Walcott delivered an energizing charge: “What we are witnessing today is not just the start of a building; it is the beginning of new capacity—capacity for local production, capacity for resilience, and capacity for Africa to rely more on itself.

“Africa’s pharmaceutical future must be built, not imported. Healthcare security depends on nations strengthening their manufacturing backbone, and AMA Medical Manufacturing is helping to write that future.”

With that, his shovel touched ground—symbolically planting a seed for what promises to become a major hub for medical logistics, manufacturing coordination, and pharmaceutical efficiency across Nigeria and beyond.

The ceremony drew a slate of high-level guests, including: Umma K. Ahamad, Commissioner of Health; Mr. Collins Scaife, CEO, Barbados Pharmaceutical Inc.; Mrs. Cindi Lewis, Deputy CEO, Barbados Pharmaceutical Inc.; Sulaiman Muhammad Adam, Chief Imam, Sultan Bello Mosque, and several other stakeholders from the pharmaceutical, investment, and health sectors. Their presence underscored the high stakes and high expectations orbiting the project.

Though the day was about the future, the history of AMA Medical Manufacturing deserved its moment in the spotlight. Located in Kaduna State, It is worthy of note that AMA-MED is a growing pharmaceutical force established to produce high-quality, lifesaving intravenous fluids (IVF)—a critical component in hospitals and emergency care nationwide.

A subsidiary of AMA Infrastructure and Investment Holdings, the company was founded on a mission to become “a leader in Africa’s medical manufacturing industry by providing reliable, world-class healthcare products that meet today’s needs and those of generations to come.”

Its vision—clear as a well-cut gem—is to be a leading partner in delivering quality, affordable, lifesaving medicines across Nigeria and far beyond its borders.

AMA-MED is not a startup testing its knees; it has already built a strong presence. Most recently, they ranked among the standout exhibitors at the 98th Annual Conference of the Pharmaceutical Society of Nigeria (PSN), where they showcased advanced IVF solutions and engaged with industry leaders on manufacturing innovation.

The incoming Central Commodity & Logistics Management Centre is expected to streamline the distribution of essential medical products, boost local production efficiency, strengthen Nigeria’s pharmaceutical supply chain, provide hundreds of jobs and support hospitals and emergency facilities with steady, reliable access to IV fluids and other medical consumables.

Stakeholders describe it as an infrastructure leap that will reduce dependency on imports and close supply gaps that often threaten patient outcomes.

As part of the groundbreaking events, dignitaries embarked on a guided tour of AMA-MED’s facilities, where they witnessed the precision-driven processes behind the company's IV fluid production.

From automated filling lines to quality-control labs humming like disciplined symphonies, the visitors got a firsthand view of the level of sophistication AMA-MED already commands—a silent but powerful argument that the new centre is not ambition, but progression.

For an industry long challenged by import dependence, FX pressure, and supply chain vulnerabilities, AMA-MED’s new project offers a refreshing gust of hope. It signals confidence, investment, expansion—and the arrival of a more self-reliant pharmaceutical future.

With shovels raised and foundations laid, Nigeria’s march toward pharmaceutical solidity continues, one deliberate block at a time.